NLRP3 and memory impairment: We found that AST-120 treatment significantly reduced both the serum and brain levels of IS (Figure 4), ameliorated NLRP3 inflammasome-induced neuroinflammation in the hippocampus, and improved short-term and long-term memory impairment in CKD mice.